HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

John W Steinke Selected Research

Sinusitis

10/2013Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
9/2012Etiology of nasal polyps in cystic fibrosis: not a unimodal disease.
1/2012Leukotriene Inhibitors in Sinusitis.
10/2011Genetics and phenotyping in chronic sinusitis.
12/2009Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis.
2/2008Role of hypoxia in inflammatory upper airway disease.
3/2007Hypoxia stimulates inflammatory and fibrotic responses from nasal-polyp derived fibroblasts.
11/2006The relationship between rhinosinusitis and asthma sinusitis.
9/2006Expression of leukotriene C4 synthase and plasminogen activator inhibitor 1 gene promoter polymorphisms in sinusitis.
6/2006Fungi in chronic hyperplastic eosinophilic sinusitis: reasonable doubt.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


John W Steinke Research Topics

Disease

21Asthma (Bronchial Asthma)
01/2022 - 02/2003
14Sinusitis
10/2013 - 02/2003
13Inflammation (Inflammations)
01/2021 - 02/2004
8Infections
01/2022 - 01/2015
7Eosinophilia
01/2021 - 02/2003
6Nasal Polyps (Nasal Polyp)
01/2016 - 06/2006
5Polyps
01/2016 - 03/2007
5Fibrosis (Cirrhosis)
10/2011 - 06/2005
3Hypersensitivity (Allergy)
01/2012 - 05/2007
3Hypoxia (Hypoxemia)
11/2008 - 03/2007
2Drug Hypersensitivity (Drug Allergy)
11/2019 - 01/2016
2Allergic Rhinitis
01/2019 - 11/2017
2Hyperplasia
11/2017 - 06/2005
2Rhinosinusitis
11/2016 - 01/2016
2Rhinitis
03/2014 - 05/2004
2Respiratory Sounds (Crackle)
03/2014 - 06/2012
2Bronchial Spasm
05/2008 - 05/2004
1Bronchial Hyperreactivity
01/2022
1Human Influenza (Influenza)
01/2022
1Gastroesophageal Reflux (GERD)
01/2021
1Agammaglobulinemia (Hypogammaglobulinemia)
01/2018
1Reinfection
01/2018
1Common Variable Immunodeficiency
01/2018
1Anaphylaxis (Anaphylactic Shock)
03/2015
1Tick Bites
03/2015
1Edema (Dropsy)
10/2011
1Hypertrophy
10/2011
1Chronic Urticaria
07/2010
1Autoimmune Diseases (Autoimmune Disease)
05/2008
1Immune System Diseases (Immune Disorders)
09/2004

Drug/Important Bio-Agent (IBA)

10Immunoglobulin E (IgE)IBA
01/2021 - 11/2004
10CytokinesIBA
01/2021 - 02/2006
8Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2019 - 06/2005
8LeukotrienesIBA
01/2019 - 05/2007
5AllergensIBA
01/2020 - 06/2012
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 03/2007
4Proteins (Proteins, Gene)FDA Link
10/2011 - 11/2004
3Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2022 - 06/2005
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 05/2008
3AntibodiesIBA
06/2012 - 02/2006
3Interleukin-4 (Interleukin 4)IBA
01/2012 - 11/2004
32-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA
11/2006 - 06/2006
2Antiviral Agents (Antivirals)IBA
01/2022 - 05/2008
2Interleukin-5 (Interleukin 5)IBA
01/2022 - 01/2019
2ChemokinesIBA
01/2021 - 05/2004
2Dinoprostone (PGE2)FDA Link
11/2019 - 01/2016
2Chemotactic FactorsIBA
01/2019 - 01/2019
2Interleukin-13IBA
11/2010 - 06/2006
2IgE Receptors (Fc epsilon RI)IBA
07/2010 - 11/2004
2cysteinyl-leukotrieneIBA
10/2009 - 02/2003
2Oxygen (Dioxygen)IBA
02/2008 - 03/2007
1LipidsIBA
01/2021
1Omalizumab (Xolair)FDA Link
01/2020
1Immunoglobulin A (IgA)IBA
01/2020
1Immunoglobulin G (IgG)IBA
01/2020
1Neutralizing AntibodiesIBA
01/2020
1Prednisone (Sone)FDA LinkGeneric
07/2019
1Leukotriene B4IBA
01/2019
1Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
01/2019
1leukotriene A4 hydrolaseIBA
01/2019
1anti-IgE antibodiesIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
11/2017
1Itraconazole (Sporanox)FDA LinkGeneric
11/2016
1Cetuximab (Erbitux)FDA Link
03/2015
1AntigensIBA
01/2015
1Viral RNAIBA
03/2014
1DNA (Deoxyribonucleic Acid)IBA
09/2012
1Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
01/2012
1RNA (Ribonucleic Acid)IBA
10/2011
1CollagenIBA
10/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2011
1Interleukin-33IBA
02/2011
1Interleukin-9 (Interleukin 9)IBA
11/2010
1AutoantibodiesIBA
07/2010
1SuspensionsIBA
12/2009
1Budesonide (Pulmicort)FDA LinkGeneric
12/2009
1TenascinIBA
11/2008
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
11/2008
1leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
05/2008
1Matrix Metalloproteinases (MMPs)IBA
02/2008
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2008
1Transforming Growth Factor beta (TGF-beta)IBA
02/2008
1ProcollagenIBA
02/2008
1Transcription Factors (Transcription Factor)IBA
02/2008
1Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2008
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2008
1Plasminogen Activator Inhibitor 1IBA
09/2006
1Plasminogen InactivatorsIBA
09/2006
1Leukotriene C4IBA
09/2006
1lysophosphatidic acidIBA
06/2006
1Messenger RNA (mRNA)IBA
06/2006
1Lysophosphatidic Acid ReceptorsIBA
06/2006
1Phospholipids (Phosphatides)FDA LinkGeneric
06/2006
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
11/2004
1Interleukin-10 (Interleukin 10)IBA
09/2004
1Leukotriene Receptors (Leukotriene Receptor)IBA
05/2004
1InterleukinsIBA
02/2004

Therapy/Procedure

4Therapeutics
01/2021 - 11/2017
1Ambulatory Care (Outpatient Care)
11/2016